Optimized New Shengmai Powder suppresses ferroptosis in ischemic cardiomyocytes via cGMP-PKG signalling.

Zhang Z, Yang Z, Jia Z, Song Y, Guo L, Wang S, Wang X, Mao J

Open source

DOI
10.1186/s13020-026-01364-6
Published
2026 Mar 6
Container
Chinese medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13020-026-01364-6,
  title = {Optimized New Shengmai Powder suppresses ferroptosis in ischemic cardiomyocytes via cGMP-PKG signalling.},
  author = {Zhang Z and Yang Z and Jia Z and Song Y and Guo L and Wang S and Wang X and Mao J},
  year = {2026},
  journal = {Chinese medicine},
  doi = {10.1186/s13020-026-01364-6},
  url = {https://doi.org/10.1186/s13020-026-01364-6}
}

RIS

TY  - JOUR
TI  - Optimized New Shengmai Powder suppresses ferroptosis in ischemic cardiomyocytes via cGMP-PKG signalling.
AU  - Zhang Z
AU  - Yang Z
AU  - Jia Z
AU  - Song Y
AU  - Guo L
AU  - Wang S
AU  - Wang X
AU  - Mao J
PY  - 2026
JO  - Chinese medicine
DO  - 10.1186/s13020-026-01364-6
UR  - https://doi.org/10.1186/s13020-026-01364-6
ER  - 

APA

Z, Z., Z, Y., Z, J., Y, S., L, G., S, W., X, W., & J, M. (2026). Optimized New Shengmai Powder suppresses ferroptosis in ischemic cardiomyocytes via cGMP-PKG signalling.. Chinese medicine. https://doi.org/10.1186/s13020-026-01364-6

Source records